Attovia Therapeutics, Inc. (ATTO) stock
Close on Nov 11, 2026Market cap $763.75MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $763.75M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.92
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $13.54
- Diluted shares
- 29M
Trading
- Previous close
- $16.64
- Open
- $16.55
- Day's range
- $16.44 – $17.37
- Volume
- 150,110
- Average volume (20 days)
- 323,686
- RSI (14 days)
- 56.0
- Relative volume
- 0.36×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ATTO | S&P 500 | Difference | ATTO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +3.2% | -2.4% | +5.6 pts | ||
| 3 months | -10.3% | -1.2% | −9.1 pts | ||
| Year to date | +3459.6% | +12.3% | +3447.3 pts | ||
| 1 year | +3459.6% | +12.4% | +3447.1 pts | ||
| 3 years | +3459.6% | +78.8% | +3380.8 pts | +229.0% | +21.4% |
| 5 years | -35.1% | +75.2% | −110.3 pts | -8.3% | +11.9% |
| 10 years | +95.7% | +311.1% | −215.4 pts | +6.9% | +15.2% |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Attovia Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
Attovia Therapeutics stock: common questions
What is Attovia Therapeutics's stock price?
ATTO closed at $16.73 on Nov 11, 2026, up 0.54% on the day.
What is Attovia Therapeutics's market cap?
Attovia Therapeutics was worth $763.75M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
Does Attovia Therapeutics pay a dividend?
No. Attovia Therapeutics has not paid a cash dividend over the last twelve months.
How has ATTO stock performed over the past year?
Including dividends, ATTO returned +3459.6% over the past year, against +12.4% for the S&P 500.
How many ATTO shares are sold short?
2M shares were sold short at the latest FINRA report, 6.12% of the float, or 4.5 days of average trading volume.
Who are Attovia Therapeutics's competitors?
Companies most similar to Attovia Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?